Encore Medical Research — Hollywood, Florida

Public research footprint of Encore Medical Research, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Diabetes Mellitus, Type 2 · Dermatitis Atopic · Overweight

Recently updated registry entries

NCT06993792 — A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight… (Active Not Recruiting)
NCT05125302 — Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the… (Recruiting)
NCT05739383 — A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Encore Medical Research?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.